Delivery Order SPE2DB24D1201-SPE2DB24FJBGT

Award Date 9/4/24
Potential Completion Date 9/5/24
Potential Value $2.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $6,063.32, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML medication. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an Ultimate Completion Date of August 23, 2024. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp, through its Corporate Office division, has been awarded...
This federal contract award, valued at $9,074.38, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to...
The U.S. Defense Logistics Agency (DLA) awarded a $1,433.67 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML. This contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs...
This federal contract award, valued at $2,206.14, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to support the DLA's healthcare programs. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of April 19, 2023. The contract is not designated...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML. The contract, valued at $1,741.68, was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of July 23, 2024. The contract is a Firm Fixed Price Delivery Order, and there is no set-aside designation. Amerisourcebergen is a significant supplier of pharmaceutical and medical products to various...
The federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML. The contract, valued at $5,598.26, was awarded by the Defense Logistics Agency (DLA) and is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML medical product. The contract has a Firm Fixed Price pricing type and a ceiling value of $4,808.20. It is a Delivery Order contract with a performance period ending on July 22, 2024. The contract does not have a set-aside designation. AmerisourceBergen holds several Indefinite Delivery Contracts...
This federal contract award, valued at $2,228.89, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML. The contract has a completion date of May 29, 2024 and is a Delivery Order with a Firm Fixed Price pricing type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML medication. The award has a ceiling value of $5,041.77 and a completion date of September 11, 2024. This is a delivery order contract with a firm fixed price pricing type. The contract is not set aside for any special designation. Amerisourcebergen has been awarded multiple federal contracts and...
This federal contract award, valued at $1,451.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML. The contract is a firm fixed-price delivery order with a completion date of July 23, 2024. Amerisourcebergen has been awarded numerous federal contracts and Indefinite Delivery Contracts (IDCs) by various government agencies, including the DLA Troop Support Medical and the...
  • SPE2DB24D1201
    Indefinite Delivery Contract
  • SPE2DB24D1201-SPE2DB24FJBGT
    Delivery Order

This federal contract award, valued at $2,940.18, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML. The contract is a delivery order with a firm fixed-price pricing type and has a period of performance through September 5, 2024. The award does not have a set-aside designation. Amerisourcebergen, through its corporate office division, has been awarded numerous federal contracts and Indefinite Delivery Contracts (IDCs) by various government agencies, including the DLA and the Department of Justice Federal Bureau of Investigation, to provide a wide range of pharmaceutical products and medical supplies to support military treatment programs, veterans' healthcare, and other federal healthcare initiatives.

Generated 12/4/24, 9:36 AM